AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Nice puts Actimize up for sale at a $1.5-2 billion price tag
3
Zafran raises $60 million and doubles valuation as it chooses independence over takeover offers
4
Israeli drone startup Heven hits $1 billion valuation in $100 million round led by IonQ
5
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
More news

Biotech

20 stories about Biotech
נאסד"ק וול סטריט

Liver Treatment Company Galmed is Raising $6 Million in Direct Offering

04.04.18|Lilach Baumer
The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014
מוסף אצות קיבוץ קטורה

Israeli Biotech Company Algatech Expands Into Asia

03.04.18|Hagar Ravet
Algatech bought a controlling stake in New Zealand-based microalgae cultivation company Supreme Health
נאסדק נאסד"ק ניו יורק בורסה בועה

CTech’s Wednesday Roundup of Israeli Tech News

28.03.18|CTech
Verint considering IPO for one of its business units, Israeli marijuana companies look to the stock market, Black Cube accused of Nigeria election meddling
חדר מיון בית חולים שיבא תל השומר

InSight Biopharmaceuticals Buys Cancer Treatment Company CureTech

28.03.18|Lilach Baumer
As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced clinical trials
חיים הורביץ איש עסקים דירקטור ב חברת טבע

Stock Market Downturn Leads Biotech Company Polypid to Backtrack on IPO

25.03.18|Dror Reich
The Israel-based company has postponed its planned IPO after Nasdaq, Dow Jones trended down heavily last week
נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Polypid Aims to Raise $75 Million with Nasdaq IPO

15.03.18|Dror Reich
The Israel-based company develops a pharmaceutical mechanism that slows down drug delivery
default image

Company that Develops Injectable Bone Grafts Expands Clinical Trial

12.03.18|Dror Reich
Unlike conventional methods, Bonus Biogroup turns fat tissue collected from patients into bone grafts that can be transplanted with a minimally invasive procedure
default image

Online Genealogy Company MyHeritage Launches Campaign to Connect Adoptees and Birth Families

04.03.18|Lilach Baumer
As part of the pro-bono initiative, the Israel-based company will provide 15,000 free DNA testing kits
ילד חולה ילדים חולים

Lung Diseases Treatment Company Raises $9.8 Million in Private Placement

27.02.18|Lilach Baumer
Israel-based AIT Therapeutics Inc. will use the funding to support its ongoing clinical programs
סטפן אושמן מנכ"ל Merck

Merck and WuXi AppTec Announce Launch of Biotech Incubator in Israel

20.02.18|Meir Orbach
The incubator program has a five year budget of 20 million euros
חיים לייבוביץ' מנכ"ל בריינסטורם

Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member

05.02.18|Dror Reich
Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases
תירס Corn אבוג'ן Evogene

DuPont-Pioneer, Evogene Announce Up to 20% Increased Corn Yield in Trials

11.01.18|Lilach Baumer and Dror Reich
Evogene uses computational predictive biology to develop novel crop strains and pesticides. Further trials are required before commercialization
default image

CTech’s Daily Israeli Tech News Roundup

07.01.18|CTech
‘Meltdown’, ‘Spectre,’ may change the way chips are designed. Kibbutz startup turns fly larvae into a protein-rich animal feed
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Enema Startup Motus GI Files for $28.8 Million Nasdaq IPO

07.01.18|Lilach Baumer
The Israel-based company develops a device that helps prepare patients better for colonoscopy
שם: מעבדה ביוטק וושי אפטק Lab Biotech WuXi AppTec

Merck, China’s WuXi AppTec to Launch Biotech Incubator in Israel

25.12.17|Meir Orbach
Israel-born businessman Mori Arkin and life sciences-focused venture capital fund Pontifax are also partners in the venture, set to launch in 2018
מעבדה של גמידה סל

Adams Street Partners Backs Critical Care Treatment Startup Atox Bio

04.12.17|Lilach Baumer
The company's leading product is currently being tested in clinical trials for the treatment of flesh-eating bacteria and kidney failure
המדען הראשי ב כלל ביוטכנולוגיה ד"ר ג'וליאן אדמס

Pharma Veteran Julian Adams takes Helm at Gamida Cell

21.11.17|Lilach Baumer
The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor
אננס אננסים

MediWound Loses Stock Purchase Agreement Case

14.11.17|Dror Reich
The burn and wound treatment company was ordered to follow through on previous agreement to buy shares of biotech company Polyheal
אננס אננסים

Biotech Company Struggling to Convince Doctors to Treat Burns with Pineapples

07.11.17|Amarelle Wenkert and Dror Reich
The story of Nasdaq-listed MediWound began with a German doctor, who searched for a way to treat the wounds of Wehrmacht soldiers stationed in North Africa
אורי יהודאי מנכ"ל ו נשיא פרוטרום

Frutarom Buys Specialty Nutrition Company Enzymotec

29.10.17|Lilach Baumer
The total amount to be paid by Frutarom for 100% of shares will be $210 million
Previous ArticlesMore Articles